RYTM
Rhythm Pharmaceuticals Inc
NASDAQ: RYTM · HEALTHCARE · BIOTECHNOLOGY
$82.12
-2.45% today
Updated 2026-04-29
Market cap
$5.61B
P/E ratio
—
P/S ratio
29.55x
EPS (TTM)
$-3.11
Dividend yield
—
52W range
$55 – $122
Volume
0.9M
Rhythm Pharmaceuticals Inc (RYTM) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $18.92M | $18.19M | $194000.00 | $37.27M | $12.34M | $151.74M | $260.21M | $308.52M | $187.07M | $329.52M | $382.48M | $332.75M | $392.27M |
| Cash & equivalents | $11.77M | $7.36M | $152000.00 | $34.87M | $6.54M | $34.24M | $49.54M | $62.29M | $100.85M | $59.25M | $127.68M | $60.08M | $89.14M |
| Current assets | $18.86M | $18.14M | $194000.00 | $35.49M | $11.18M | $150.67M | $258.69M | $302.40M | $181.67M | $308.39M | $354.24M | $308.27M | $374.20M |
| Total liabilities | $55.21M | $75.65M | $552000.00 | $5.27M | $5.04M | $6.95M | $13.95M | $27.50M | $20.55M | $45.37M | $118.22M | $162.99M | $227.72M |
| Current liabilities | $2.50M | $3.06M | $552000.00 | $5.27M | $4.73M | $6.72M | $13.58M | $24.42M | $17.99M | $43.43M | $39.81M | $55.20M | $115.52M |
| Long-term debt | — | — | — | — | — | $0.00 | — | — | — | — | $1.34M | — | — |
| Shareholder equity | $-36.28M | $-57.46M | $-358000.00 | $32.00M | $7.30M | $144.79M | $246.26M | $281.02M | $166.53M | $284.15M | $264.26M | $169.76M | $164.55M |
| Retained earnings | $-37.01M | $-58.44M | $-39.60M | $-50.67M | $-76.54M | $-110.25M | $-184.60M | $-325.33M | $-459.33M | $-528.94M | $-710.06M | $-894.74M | $-1.16B |
| Accounts receivable | — | — | — | — | — | — | — | — | $0.00 | $1.02M | $6.22M | $14.87M | $18.51M |
| Inventory | — | — | — | — | — | $0.00 | — | — | — | $111000.00 | $2.92M | $8.62M | $18.74M |
| Goodwill | — | — | — | — | — | $0.00 | — | — | — | — | — | — | — |